Chemed Corporation (CHE) Q2 2025 Earnings Call Transcript
Chemed Corporation (NYSE:CHE ) Q2 2025 Earnings Conference Call July 30, 2025 10:00 AM ET Company Participants Holley Schmidt - Corporate Participant Kevin J. McNamara - CEO, President & Director Michael D.
Chemed (CHE) Q2 Earnings Miss Estimates
Chemed (CHE) came out with quarterly earnings of $4.27 per share, missing the Zacks Consensus Estimate of $4.78 per share. This compares to earnings of $5.47 per share a year ago.
Analysts Estimate Chemed (CHE) to Report a Decline in Earnings: What to Look Out for
Chemed (CHE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Chemed Corporation: Short-Term Headwinds But Long-Term Growth Potential
Chemed Corporation's diversified revenue streams from VITAS Healthcare and Roto-Rooter provide a strong competitive advantage and resilience against sector-specific risks. Recent VITAS acquisition and expansion, along with robust Q1 results, highlight the company's growth potential and operational strength, especially in hospice care. My DCF analysis suggests Chemed is undervalued by over 50%, with a fair value estimate of $744 per share, supporting a buy rating.
Chemed (CHE) Up 2.7% Since Last Earnings Report: Can It Continue?
Chemed (CHE) reported earnings 30 days ago. What's next for the stock?
CHE Stock Falls Despite Q1 Earnings & Revenue Beat, Gross Margin Declines
Chemed delivers first-quarter top-line growth across two of its segments, VITAS and Roto-Rooter.
Chemed Corporation (CHE) Q1 2025 Earnings Call Transcript
Chemed Corporation (NYSE:CHE ) Q1 2025 Earnings Conference Call April 24, 2025 10:00 AM ET Company Participants Holley Schmidt - Assistant Controller Kevin McNamara - President and CEO Mike Witzeman - CFO Nick Westfall - Chairman and CEO, Chemed VITAS Healthcare Corporation Conference Call Participants Ben Hendrix - RBC Capital Markets Operator Good day, and thank you for standing by. Welcome to the Chemed Corporation First Quarter 2025 Earnings Conference Call.
Chemed (CHE) Surpasses Q1 Earnings and Revenue Estimates
Chemed (CHE) came out with quarterly earnings of $5.63 per share, beating the Zacks Consensus Estimate of $5.60 per share. This compares to earnings of $5.20 per share a year ago.
Why Is Chemed (CHE) Up 4.5% Since Last Earnings Report?
Chemed (CHE) reported earnings 30 days ago. What's next for the stock?
Chemed Q4 Earnings & Revenues Top, Stock Climbs, Margins Contract
CHE's earnings and revenues beat estimates in the fourth quarter of 2024.
Chemed Corporation (CHE) Q4 2024 Earnings Call Transcript
Chemed Corporation (NYSE:CHE ) Q4 2024 Earnings Conference Call February 27, 2025 10:00 AM ET Company Participants Holley Schmidt – Assistant Controller Kevin McNamara – President and Chief Executive Officer Mike Witzeman – Chief Financial Officer Nick Westfall – Chairman and Chief Executive Officer, Chemed VITAS Healthcare Corporation Conference Call Participants Michael Murray – RBC Capital Markets Christian Porter – Bank of America Operator Hello, and welcome to the Chemed Corporation Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Chemed (CHE) Surpasses Q4 Earnings and Revenue Estimates
Chemed (CHE) came out with quarterly earnings of $6.83 per share, beating the Zacks Consensus Estimate of $6.79 per share. This compares to earnings of $6.60 per share a year ago.
